Varenicline for smoking cessation
86 results
1 - 86Varenicline effective for smoking cessation
Varenicline (Chantix) effective for smoking cessation
Varenicline for smoking cessation
Varenicline for smoking cessation in individuals with schizophrenia
Varenicline, bupropion, nicotine replacement all effective for smoking cessation
Cytisine unable to demonstrate noninferiority to varenicline, but is still an option for smoking cessation
No benefit to varenicline beyond 12 weeks or combined with nicotine replacement therapy for smoking cessation
Nicotine receptor partial agonists for smoking cessation: Cochrane systematic review
Smoking cessation
Counseling is equal to varenicline to help adolescents quit smoking
Varenicline plus nicotine replacement therapy more effective than varenicline alone
Maintenance treatment with varenicline improves smoking cessation in patients with schizophrenia and bipolar disorder
Interventions for smoking cessation and reduction in individuals with schizophrenia New search for studies and content updated (no change to conclusions)
Varenicline similar in effectiveness to nicotine patch
Smoking cessation medication for preventing weight gain after cessation
Combo treatment better than varenicline alone in male and highly dependent smokers
Varenicline (Chantix) not associated with increased CV events
Varenicline effective for smokers preferring to "cut down" rather than quit "cold turkey"
Varenicline and bupropion and suicidal behaviour
Interventions for preoperative smoking cessation: Cochrane systematic review
Varenicline plus bupropion SR no better than varenicline alone for tobacco cessation
American Thoracic Society guideline for initiating medications for smoking cessation
Interventions for smoking cessation in hospitalised patients: Cochrane systematic review
Interventions for smoking cessation in patients with psyhiatric disorders
Antidepressants for smoking cessation Edited (no change to conclusions)
Antidepressants for smoking cessation
Varenicline increases smokeless tobacco cessation
Varenicline, bupropion may not increase risk of cardiovascular events
Pharmacological interventions for smoking cessation: an overview and network meta‐analysis Edited (no change to conclusions)
Pharmacological interventions for promoting smoking cessation during pregnancy New search for studies and content updated (no change to conclusions)
Smoking cessation for people with chronic obstructive pulmonary disease
Smoking cessation interventions for smokers with current or past depression: Cochrane systematic review
USPSTF 2021 updates on effective interventions for tobacco smoking cessation in adults, including pregnant persons
Interventions for smoking cessation in Indigenous populations: Cochrane systematic review
Relapse prevention interventions for smoking cessation
Varenicline increases risk of adverse CV events
Smoking reduction interventions for smoking cessation New
Training health professionals in smoking cessation Edited (no change to conclusions)
Nicotine replacement therapy for smoking cessation
Relapse prevention interventions for smoking cessation New search for studies and content updated (no change to conclusions)
Inpatient smoking cessation strategy promising, but effects aren't long lasting
Pharmacological interventions for promoting smoking cessation during pregnancy
Interventions for smokeless tobacco use cessation Edited (no change to conclusions)
Cytisine is inexpensive, safe, and modestly effective for smoking cessation
Interventions for preventing weight gain after smoking cessation Edited (no change to conclusions)
Combined nicotine replacement therapy for smoking cessation
Interventions to reduce harm from continued tobacco use Edited (no change to conclusions)
Combined pharmacotherapy and behavioural interventions for smoking cessation: Cochrane systematic review
Cytisine more effective than nicotine for smoking cessation, but with more adverse effects
Postdischarge tobacco cessation intervention results in higher quit rates for hospitalized smokers
Smoking cessation for people with chronic obstructive pulmonary disease Edited (no change to conclusions)
Schizophrenia
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation New search for studies and content updated (no change to conclusions)
Interventions for recruiting smokers into cessation programmes
Interventions to increase adherence to medications for tobacco dependence New search for studies and content updated (no change to conclusions)
Nicotine replacement therapy to reduce continued tobacco use
Electronic cigarettes for smoking cessation Edited (no change to conclusions)